Home Tags PVX108

Dr Pascal Hickey from Aravax (left) and Dr Chris Smith from Brandon Capital

Aravax Testing New Way to Tackle Food Allergy

News Wire ~ 3rd Party Press Release - 2024/11/15 0

Aravax’s Phase 2 Study Now Enrolling Children with Peanut Allergy

Aravax - 2024/05/21 0

Promising Food Allergy Treatment from Aravax Receives $12 Million Investment

Dave Bloom - 2024/01/23 0

Aravax Doses First Patient in Phase 2 Peanut Allergy Clinical Trial

News Wire ~ 3rd Party Press Release - 2023/06/01 0

FDA Green Lights Phase 2 Trials of PVX108, a Novel Peptide-Driven...

News Wire ~ 3rd Party Press Release - 2022/03/04 0

Aravax Presents Additional Positive Phase I Trial Results for PVX108, a...

News Wire ~ 3rd Party Press Release - 2019/06/05 0

Phase I Trial for New Peanut Allergy Immunotherapy Results in No...

Dave Bloom - 2019/02/24 0

Novel Peanut Allergy Vaccine Begins Phase I Clinical Trials

Dave Bloom - 2017/05/22 0

Put Your School on the Map

Dave Bloom - 2024/07/31 0

Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

Tag: PVX108